scispace - formally typeset
T

Tai-Shuan Lai

Researcher at National Taiwan University

Publications -  70
Citations -  851

Tai-Shuan Lai is an academic researcher from National Taiwan University. The author has contributed to research in topics: Kidney disease & Medicine. The author has an hindex of 12, co-authored 48 publications receiving 627 citations.

Papers
More filters
Journal ArticleDOI

Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.

TL;DR: A meta-analysis suggests that even in those with ICDs, there is still a 2.7-fold increased mortality risk in patients who receive dialysis compared with those who do not, and Beta blockers may be less cardioprotective in patients with I CDs who are on dialysis.
Journal ArticleDOI

Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs

TL;DR: It is demonstrated that the multidisciplinary care program provided better health care and reduced renal replacement therapy in patients with advanced chronic kidney disease by decreasing hospitalizations, emergent start, and the need for kidneys replacement therapy, and was cost-effective.
Journal ArticleDOI

Risk of developing severe sepsis after acute kidney injury: a population-based cohort study.

TL;DR: Dialysis-requiring AKI patients had a higher risk of developing de novo severe sepsis than the non-AKI group and even patients who recovered from AKI had a high risk of long-term severe Sepsis.
Journal ArticleDOI

Long-term remote organ consequences following acute kidney injury.

TL;DR: The data from experimental studies to clinical outcome studies in the field of organ crosstalk following AKI was summarized and the long-term consequences of distant organ-system, including liver, heart, brain, lung, gut, bone, immune system, and malignancy followingAKI with temporary dialysis were reviewed and discussed.
Journal ArticleDOI

Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study

TL;DR: It is revealed that chronic HCV infection is associated with an increased risk of developing ESRD and suggests that elevated serum levels of HCV RNA (>167,000 IU/mL) and HCV genotype 1 are strong predictors of ESRd, indicating clinical implications for the management of chronicHCV.